Page last updated: 2024-08-24

irinotecan and Hypercoagulability

irinotecan has been researched along with Hypercoagulability in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ilson, D; Kelsen, DP; Shah, MA	1

Trials

1 trial(s) available for irinotecan and Hypercoagulability

Article	Year
Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-10, Volume: 23, Issue:11 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Humans; Incidence; Irinotecan; Risk Factors; Stomach Neoplasms; Thromboembolism; Thrombophilia	2005

Article

Year

Thromboembolic events in gastric cancer: high incidence in patients receiving irinotecan- and bevacizumab-based therapy.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Apr-10, Volume: 23, Issue:11

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Humans; Incidence; Irinotecan; Risk Factors; Stomach Neoplasms; Thromboembolism; Thrombophilia

2005